Anzeige
Meldung des Tages: SGS liefert den Ritterschlag: Weltklasse-Tests machen aus einem Explorer plötzlich ein Industrie-Asset

Bavarian Nordic Aktie News

Aktie
WKN:  917165 ISIN:  DK0015998017 US-Symbol:  BVNKF Branche:  Biotechnologie Land:  Dänemark
26,12 €
+0,01 €
+0,04%
21.01.26
Depot/Watchlist
Marktkapitalisierung *
1,97 Mrd. €
Streubesitz
70,67%
KGV
15,06
neu: Nachhaltigkeits-Score
64 %
Index-Zuordnung
-

Bavarian Nordic News

17.12.25 - GlobeNewswire
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
COPENHAGEN, Denmark, December 17, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that, following the recent appointment of Anne Louise Eberhard as new Chair of ...
02.12.25 - GlobeNewswire
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
COPENHAGEN, Denmark, December 2, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced its intent to launch a one-time share buy-back program of up to DKK 500 million to ...
26.11.25 - GlobeNewswire
Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen
COPENHAGEN, Denmark, November 26, 2025 – Bavarian Nordic A/S invites its shareholders for a meeting and dialogue with the company’s board and management, who will ...
14.11.25 - wallstreetONLINE Redaktion
Biotech unter Druck: Zahlen top, Aktie flop: Bavarian Nordic rutscht ins Minus!
Bavarian Nordic steigert Umsatz und Ergebnis deutlich und präzisiert die Jahres­prognose, doch die Aktie rutscht ab. Ein überraschender Rückzug sorgt für Unruhe.Das dänische ...
14.11.25 - GlobeNewswire
Bavarian Nordic Announces Interim Results for the First Nine Months of 2025
COPENHAGEN, Denmark, November 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2025 and business ...
13.11.25 - GlobeNewswire
Bavarian Nordic Announces Changes to the Board of Directors
COPENHAGEN, Denmark, November 13, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Chair of the Board, Luc Debruyne has decided to step down from the board ...
01.11.25 - GlobeNewswire
Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business
COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and Response Authority ...
31.10.25 - GlobeNewswire
Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox
New and larger framework contract with the European Commission’s Health Emergency Preparedness and Response Authority (HERA) replaces previous agreement and provides ...
28.10.25 - GlobeNewswire
Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines
COPENHAGEN, Denmark, October 28, 2025 – Bavarian Nordic announced today a donation of mpox vaccines to Africa CDC to support the response to the ongoing mpox outbreak in ...
07.10.25 - GlobeNewswire
Bavarian Nordic Reports Positive Topline Data for Mpox/Smallpox Vaccine in Pediatric Population
Primary endpoint was met in clinical study, demonstrating a comparable safety profile and a non-​inferior immune response for MVA-BN in children aged 2-11 years compared to ...
22.08.25 - wallstreetONLINE Redaktion
Gewinne ziehen an: Kurz vor Milliarden-Deal: Dieses Biotech-Unternehmen sprengt die Erwartungen
Starke Umsätze und steigende Gewinne stärken die Position des Impfstoffherstellers Bavarian Nordic. Kurz vor dem Milliarden-​Deal wächst die Spannung.Der dänische ...
22.08.25 - GlobeNewswire
Bavarian Nordic Announces First Half 2025 Results
COPENHAGEN, Denmark, August 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2025 and ...
31.07.25 - GlobeNewswire
Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance
COPENHAGEN, Denmark, July 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its Priority Review Voucher (PRV). Upon completion, the ...
28.07.25 - dpa-AFX
AKTIE IM FOKUS: Evotec legen weiter zu - Positives Umfeld, Bavarian Nordic
FRANKFURT/KOPENHAGEN (dpa-AFX Broker) - Die Aktien von Evotec haben am Montag auf dem höchsten Stand seit Mitte Juni von positiven Nachrichten für die Branche profitiert. ...
28.07.25 - GlobeNewswire
Consortium Led by Nordic Capital and Permira Will Make All-Cash Recommended Purchase Offer for Bavarian Nordic
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF ...
24.07.25 - GlobeNewswire
Rumours of a Potential Takeover Offer for Bavarian Nordic A/S
COPENHAGEN, Denmark, July 24, 2025 – Bavarian Nordic A/S (OMX: BAVA) has become aware of market rumours regarding a potential takeover offer for Bavarian Nordic A/S by a ...
22.07.25 - GlobeNewswire
Bavarian Nordic Receives Acceptance from Health Canada for Review of the New Drug Submission for its Chikungunya Vaccine
COPENHAGEN, Denmark, July 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Health Canada has accepted for review the Company’s application for licensure of ...
09.07.25 - GlobeNewswire
Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country
Recurring order from an undisclosed European country to strengthen public preparedness. Combined with other recent orders from non-​European countries, the Company has now ...
26.06.25 - GlobeNewswire
Bavarian Nordic Announces the Initiation of Clinical Trials of Mpox Vaccine in Infants and Pregnant Women
First studies to evaluate MVA-BN in infants under 2 years of age and pregnant and breastfeeding women. The multi-​partner research project is aimed at expanding access to mpox ...
18.06.25 - GlobeNewswire
Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million
COPENHAGEN, Denmark, June 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that it has entered into an agreement to sell its Priority Review Voucher (PRV) for a total ...

Newssuche

Videos

newspaper
20.01.26 +5,33%
Technical Trading: Gold Zukauf
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »